OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 06/19/2025 at 08:30, 1 year 3 months ago

Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO de services précliniques en microbiologie afin de se diversifier et de renforcer sa présence en région toulousaine
Oxurion NV signe une lettre d'intention pour l'acquisition de 70% d'une société spécialisée en microbiologie appliquée à la santé humaine et animale, dermocosmétiques et nutraceutiques

Acquisition Biopharmaceutique Lettre D'intention Oxurion NV Microbiologie Appliquée
BRIEF

published on 06/18/2025 at 18:05, 1 year 3 months ago

Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
BRIEF

published on 06/18/2025 at 18:05, 1 year 3 months ago

Oxurion annonce une notification de transparence de la part d'Atlas Special Opportunities II LLC

Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas Structure De Propriété
PRESS RELEASE

published on 06/18/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE

published on 06/18/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC, verlaagt aandeel tot onder drempel 20%. Biofarmaceutisch bedrijf in Leuven kondigt belangrijke ontwikkeling aan

Transparantiekennisgeving Oxurion NV Biofarmaceutisch België Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 18:05, 1 year 3 months ago

Oxurion Reports Transparency Notification Amendments

Transparency Notification Biopharmaceutical Industry Shareholding Changes Oxurion NV Atlas Special Opportunities II
BRIEF

published on 06/12/2025 at 18:05, 1 year 3 months ago

Oxurion annonce des modifications à sa notification de transparence

Industrie Biopharmaceutique Notification De Transparence Oxurion NV Changements Dans L'actionnariat Atlas Opportunités Spéciales II
PRESS RELEASE

published on 06/12/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
PRESS RELEASE

published on 06/12/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aankoop en verkoop van aandelen en stemrechtverlenende effecten volgens Belgische transparantiewetgeving

Transparantiekennisgevingen Aandelen Oxurion NV Belgische Transparantiewetgeving Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 08:35, 1 year 3 months ago

Oxurion progresse dans son acquisition d'Axiodis

Acquisition Sciences De La Vie Oxurion Axiodis FDI France

Published on 09/26/2026 at 01:00, 12 hours 57 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 12 hours 57 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 15 hours 42 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 20 hours 27 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 22 hours 57 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 07:45, 6 hours 11 minutes ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 13 hours 55 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 19 hours 27 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 19 hours 42 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 19 hours 57 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26

View all EQS

Published on 09/26/2026 at 07:00, 6 hours 57 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 19 hours 57 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 19 hours 57 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 20 hours 12 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 20 hours 17 minutes ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE

News